Rock Creek Group, LP Abb Vie Inc. Transaction History

Rock Creek Group, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $61,985 - $71,757	-464 Reduced 22.23%	1,623 $241,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $59,762 - $74,369	-451 Reduced 17.77%	2,087 $281,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $11,134 - $12,823	-77 Reduced 2.94%	2,538 $404,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $8,436 - $10,118	-61 Reduced 2.28%	2,615 $422,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $26,170 - $30,016	195 Added 7.86%	2,676 $359,000
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $117,389 - $149,240	-853 Reduced 25.58%	2,481 $380,000
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $178,700 - $221,717	1,354 Added 68.38%	3,334 $540,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $11,924 - $15,088	111 Added 5.94%	1,980 $268,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $176,624 - $200,494	-1,660 Reduced 47.04%	1,869 $202,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $89,744 - $99,980	853 Added 31.88%	3,529 $398,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $191,914 - $211,275	-1,876 Reduced 41.21%	2,676 $290,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $359,226 - $484,994	-4,463 Reduced 49.51%	4,552 $488,000
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $166,923 - $195,912	1,943 Added 27.47%	9,015 $790,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $518,872 - $694,328	7,072 New	7,072 $694,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.